Results 211 to 220 of about 843,336 (254)

Treatment of coronary in-stent restenosis: a systematic review

Journal of Geriatric Cardiology, 2018
Coronary stent implantation has significantly improved percutaneous coronary intervention and enabled the management of early complications of plain balloon angioplasty. However, a new complication has accompanied these improvements: in-stent restenosis (
L. Pleva, Pavel Kukla, O. Hlinomaz
semanticscholar   +1 more source

Coronary dissection: A predictor of restenosis?

American Heart Journal, 1988
To determine if arterial dissection resulting from transluminal coronary angioplasty (TCA) leads to a greater incidence of restenosis, 273 consecutive patients who had undergone TCA with at least 1 year of follow-up were examined. Success was graded as a greater than or equal to 20% increase in intraluminal diameter.
Carolyn J Ewels, Bradford J Matthews, Kenneth M. Kent   +2 more
openaire   +3 more sources

Intravascular Brachytherapy for the Management of Repeated Multimetal-Layered Drug-Eluting Coronary Stent Restenosis

Circulation. Cardiovascular Interventions, 2018
Background: Because of the widespread acceptance of percutaneous coronary intervention with drug-eluting stents as an effective treatment strategy for in-stent restenosis, it is common to encounter multimetal layer stent restenosis in the recent years ...
M. Varghese, Samit Bhatheja, U. Baber, Safwan Kezbor, Aditi Chincholi, Surbhi Chamaria, M. Buckstein, R. Bakst, A. Kini, Samin K. Sharma   +9 more
semanticscholar   +1 more source

Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical Trial.

Journal of the American Medical Association (JAMA)
Importance Drug-coated balloons offer a potentially beneficial treatment strategy for the management of coronary in-stent restenosis. However, none have been previously evaluated or approved for use in coronary circulation in the United States ...
Robert W. Yeh, R. Shlofmitz, Jeffrey Moses, W. Bachinsky, S. Dohad, Steven G. Rudick, R. Stoler, Brian K. Jefferson, William J. Nicholson, John D. Altman, Cinthia T. Bateman, Amar Krishnaswamy, J. Grantham, Frank J. Zidar, S. Marso, J. Tremmel, Cindy Grines, Mustafa I. Ahmed, A. Latib, Behnam N. Tehrani, J. Abbott, Wayne B. Batchelor, Paul Underwood, Dominic Allocco, Ajay J. Kirtane, R. Shlofmitz, Jeffrey Moses, W. Bachinsky, S. Dohad, Steven G. Rudick, R. Stoler, Brian K. Jefferson, William J. Nicholson, John D. Altman, Robert W. Yeh, Cinthia T. Bateman, Amar Krishnaswamy, J. Grantham, Frank J. Zidar, Rajendran Sabapathy, J. Tremmel, Cindy Grines, Mustafa I. Ahmed, A. Latib, Behnam N. Tehrani, K. Alaswad, Carey Kimmelstiel, William Dixon, Arthur Reitman, Lawrence Ang, Justin Levisay, J. Abbott, Kathleen E. Kearney, F. Jaffer, Saroj Neupane, Kevin Croce, K. Shunk, Angela Taylor, Matthew Saybolt, Claro Diaz, Alpesh Shah, K. Lotun, Johannes Brechtken, Himanshu Agarwal, Rajan Patel   +64 more
semanticscholar   +1 more source

Coronary Brachytherapy and Restenosis

Heart Drug, 2001
The antiproliferative effects of radiotherapy have been used clinically for over 100 years to treat several benign disorders. More recently, several experimental studies have convincingly demonstrated that the use of intracoronary radiotherapy results in marked modulation of the restenotic process.
Philip Urban, D. Latchem
openaire   +2 more sources

Coronary In-Stent Restenosis: Assessment with CT Coronary Angiography

Radiology, 2012
To compare accuracy and radiation exposure of a new computed tomographic (CT) scanner with improved spatial resolution (scanner A) with those of a CT scanner with standard spatial resolution (scanner B) for evaluation of coronary in-stent restenosis (ISR) by using invasive coronary angiography (ICA) and intravascular ultrasonography (US) as reference ...
D. Andreini, G. Pontone, S. Mushtaq, A.L. Bartorelli, E. Bertella, D. Trabattoni, P. Montorsi, S. Galli, C. Foti, A. Annoni, F. Bovis, G. Ballerini, P. Agostoni, C. Fiorentini, M. Pepi   +14 more
openaire   +3 more sources

Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.

EuroIntervention, 2015
AIMS Treatment of bare metal in-stent restenosis with the paclitaxel-coated balloon catheter based on the PACCOCATH® technology has yielded superior six-month angiographic and one-year clinical results compared to a paclitaxel-eluting stent.
M. Unverdorben, C. Vallbracht, B. Cremers, H. Heuer, C. Hengstenberg, C. Maikowski, G. Werner, D. Antoni, F. Kleber, W. Bocksch, M. Leschke, H. Ackermann, M. Boxberger, U. Speck, R. Degenhardt, B. Scheller   +15 more
semanticscholar   +1 more source

Potential role of human cytomegalovirus and p53 interaction in coronary restenosis.

Science, 1994
A subset of patients who have undergone coronary angioplasty develop restenosis, a vessel renarrowing characterized by excessive proliferation of smooth muscle cells (SMCs).
E. Speir, R. Modali, E. Huang, M. Leon, F. Shawl, T. Finkel, Stephen E. Epstein   +6 more
semanticscholar   +1 more source

Restenosis in intervened coronaries with hyperhomocysteinemia (RICH)

American Heart Journal, 2003
Controversy exists regarding the contribution made by elevated serum homocysteine evels in raising the risk of restenosis after percutaneous coronary interventions. The objective of this study was to determine whether elevated homocysteine evels increase the risk of restenosis.Two hundred and two consecutive patients undergoing percutaneous coronary ...
Michael B. Jorgensen, Raoul J. Burchette, Samuel A Kojoglanian, Girma Wolde-Tsadik, Vicken Aharonian   +4 more
openaire   +3 more sources

Consequences of restenosis after coronary angioplasty

International Journal of Cardiology, 1991
The consequences of restenosis after angioplasty were evaluated in 466 patients who had coronary angiography 3 to 12 months after successful coronary angioplasty and were followed long term. The 236 subjects with restenosis resembled the 230 without restenosis with respect to age, sex, presence of multivessel disease, mean ejection fraction, prior ...
Richard J. Rodeheffer, Ronald E. Vlietstra, Kent R. Bailey, David R. Holmes   +3 more
openaire   +3 more sources